Accessibility Menu
Bristol Myers Squibb logo

Bristol Myers Squibb

(NYSE) BMY

Current Price$55.15
Market Cap$112.31B
Since IPO (1968)+18,477%
5 Year+3%
1 Year+24%
1 Month-7%

Bristol Myers Squibb Financials at a Glance

Market Cap

$112.31B

Revenue (TTM)

$48.48B

Net Income (TTM)

$7.28B

EPS (TTM)

$3.56

P/E Ratio

15.44

Dividend

$2.50

Beta (Volatility)

0.30 (Low)

Price

$55.15

Volume

18,905,777

Open

$56.00

Previous Close

$55.00

Daily Range

$54.78 - $56.59

52-Week Range

$42.52 - $62.89

Estimated Earnings Date

Jul 30, 2026

BMY: Motley Fool Moneyball Superscore

66

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bristol Myers Squibb

Industry

Pharmaceuticals

Employees

32,500

CEO

Christopher S. Boerner, PhD, MBA

Headquarters

Princeton, NJ 08543, US

BMY Financials

Key Financial Metrics (TTM)

Gross Margin

68.75%

Operating Margin

25.67%

Net Income Margin

15.01%

Return on Equity

39.05%

Return on Capital

19.35%

Return on Assets

8.41%

Earnings Yield

6.48%

Dividend Yield

4.55%

Payout Ratio

69.69%

Stock Overview

Market Cap

$112.31B

Shares Outstanding

2.04B

Volume

18.91M

Avg. Volume

11.16M

Financials (TTM)

Gross Profit

$33.33B

Operating Income

$12.45B

EBITDA

$13.75B

Operating Cash Flow

$13.31B

Capital Expenditure

-$1.40B

Free Cash Flow

$11.91B

Cash & ST Invst.

$10.49B

Total Debt

$44.46B

Bristol Myers Squibb Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$11.49B

+2.6%

Gross Profit

$8.07B

+9.9%

Gross Margin

70.22%

N/A

Market Cap

$112.31B

N/A

Market Cap/Employee

$3.29M

N/A

Employees

34,100

N/A

Net Income

$2.68B

+9.0%

EBITDA

$3.68B

-17.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$10.49B

-11.0%

Total Debt

$44.46B

-13.2%

Accounts Receivable

$12.08B

-17.2%

Inventory

$2.76B

+3.4%

Long Term Debt

$42.15B

-11.3%

Short Term Debt

$2.31B

-38.1%

Return on Assets

8.41%

N/A

Return on Invested Capital

18.49%

N/A

Free Cash Flow

$757.00M

-55.3%

Operating Cash Flow

$1.10B

-43.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VRTXVertex Pharmaceuticals Incorporated
$475.20+1.45%
GSKGSK plc
$51.09-1.88%
SNYSanofi
$41.33-0.65%
CVSCVS Health Corp.
$101.87+0.30%

Trending Stocks

Symbol / CompanyPricePrice Chg
WENWendy's
$7.86+0.26%
AALAmerican Airlines Group
$17.44+0.08%
IBITiShares Bitcoin Trust
$33.87-0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.27+0.01%

Questions About BMY

What is the current price of Bristol Myers Squibb?

Bristol Myers Squibb is trading at $55.00 per share.

What is the 52-week range for Bristol Myers Squibb?

Over the past 52 weeks, Bristol Myers Squibb has traded between $42.52 and $62.89.

How much debt does Bristol Myers Squibb have?

As of the most recent reporting period, Bristol Myers Squibb reported total debt of $46.43B.

How much cash does Bristol Myers Squibb have on hand?

Bristol Myers Squibb reported $9.57B in cash and cash equivalents in its most recent financial results.

What is Bristol Myers Squibb’s dividend yield?

Bristol Myers Squibb currently has a dividend yield of 4.55%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.